Theriva Biologics
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $154 | $0 |
Gross Profit | -27 | -26 | 77 | -33 |
EBITDA | -13,031 | -4,417 | -10,778 | -5,003 |
EBIT | -13,058 | -4,443 | -10,805 | -5,036 |
Net Income | -13,058 | -4,324 | -4,447 | -7,726 |
Net Change In Cash | 0 | 0 | 154 | 0 |
Free Cash Flow | -4,728 | -4,756 | -4,691 | -3,913 |
Cash | 12,120 | 10,014 | 11,609 | 16,409 |
Basic Shares | 6,752 | 2,782 | 1,348 | 1,134 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -137 | -135 | -268 | -87 |
EBITDA | -25,516 | -19,854 | -19,205 | -14,187 |
EBIT | -25,653 | -19,989 | -19,290 | -14,274 |
Net Income | -25,653 | -18,349 | -19,685 | -14,174 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -16,938 | -19,198 | -19,198 | -12,904 |
Cash | 11,609 | 23,177 | 41,786 | 67,325 |
Basic Shares | 1,348 | 644 | 613 | 12,187 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.93 |
2025-03-31 | -$1.55 |
2024-12-31 | -$11.49 |
2024-09-30 | -$6.81 |
